Send the following on WhatsApp
Continue to ChatEMA recommends restrictions in use of cyproterone due to meningioma risk https://allaboutpharmacovigilance.org/ema-recommends-restrictions-in-use-of-cyproterone-due-to-meningioma-risk/
EMA recommends restrictions in use of cyproterone due to meningioma risk https://allaboutpharmacovigilance.org/ema-recommends-restrictions-in-use-of-cyproterone-due-to-meningioma-risk/